BIT
Click for more information
7.50% 3.7¢ biotron limited

Also these were “humanised mice” designed to be infected with...

  1. Beno77
    5,309 Posts.
    lightbulb Created with Sketch. 653
    clock Created with Sketch.
    12/12/21
    12:18
    Post #: 58239193
    Also these were “humanised mice” designed to be infected with Covid 19 to test for the efficacy of BIT225.
    Study shows almost 100% efficacy.

    Now the reason Biotron is likely to be accepted straight into a phase 2 human trials is because the drug has a very good safety profile and is currently being used in 2 HIV studies on humans right now.
    BIT Price at posting: 8.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 8  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

ALK Alkane Resources hit 57.2Kozpa gold production through FY24 – and eyeing 70Ktpa in FY26
right-arrow Created with Sketch.
AWJ Auric jumps 10% on maiden cash sales in Q3CY24 and firm guidance
right-arrow Created with Sketch.
AHK Ark Mines defines significant exploration target at Sandy Mitchell rare earths project
right-arrow Created with Sketch.
CUV British study shows Clinuvel drug effective on DNA of UV-damaged skin
right-arrow Created with Sketch.
NEWS The Big Deal: Free-to-air TV swings the axe, but will it be enough as enormous sports deal bills loom?
right-arrow Created with Sketch.
ARU Cashed up Arafura locks in $171M German export agency deal; locks in NdPr offtake for wind turbines
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
3.7¢ 		Change
-0.003(7.50%) 		Mkt cap ! $33.38M
Open High Low Value Volume
3.8¢ 4.0¢ 3.7¢ $13.74K 361.7K

Buyers (Bids)

No. Vol. Price($)
1 421052 3.8¢
 

Sellers (Offers)

Price($) Vol. No.
3.9¢ 19000 1
View Market Depth
Last trade - 15.39pm 05/07/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.